Algene goes hunting for Alzheimer's genes
This article was originally published in Clinica
Executive Summary
Algene Biotechnologies has granted Montreal University a Can$5.3 million research grant to clone and sequence Alzheimer's disease genes. The genes lie somewhere in five chromosomal regions linked to early-onset Alzheimer's disease during a founder population study (populations with a limited number of ancestors in their recent history). The work will be carried out at the university's geriatric care unit at the Centre Hospitalier Cote-des Neiges.